MRK vs GEHC
By Alex · Tickerpine
Merck & Co., Inc. vs GE HealthCare Technologies Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | GEHC |
|---|---|---|
| Price | $147.76 | $83.02 |
| Market cap | $364.26B | $37.54B |
| P/E ratio | 149.3 | 17.6 |
| ROE | 5.06% | 20.01% |
| Profit margin | 3.64% | 9.95% |
| Revenue growth | 4.70% | 7.20% |
| Dividend yield | 2.30% | 0.19% |
| Beta | 0.12 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs GEHC in plain English
- MRK is the bigger company — about 9.7× the market cap of GEHC.
- GEHC is cheaper on earnings (P/E 17.6 vs 149.3).
- GEHC earns a higher return on equity (20% vs 5%).
- GEHC is growing revenue faster (7% vs 5%).
- MRK has the higher dividend yield (2.30% vs 0.19%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
GEHC return calculator
See what $1,000 in GE HealthCare Technologies Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.